We are live on ! Find out more
SRC

Stone Run Capital Portfolio holdings

AUM $254M
1-Year Est. Return 12.86%
This Fund
S&P 500
This Quarter Est. Return
+19.65%
1 Year Est. Return
+12.86%
3 Year Est. Return
+77.77%
5 Year Est. Return
+98.28%
10 Year Est. Return
+404.21%
AUM
$203M
AUM Growth
+$42.7M
Cap. Flow
+$11.4M
Cap. Flow %
5.61%
Top 10 Hldgs %
35.86%
Holding
61
New
2
Increased
15
Reduced
13
Closed

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$3.36M
2
XRAY icon
Dentsply Sirona
XRAY
+$3.23M
3
WAB icon
Wabtec
WAB
+$2.79M
4
MIDD icon
Middleby
MIDD
+$696K
5
DHR icon
Danaher
DHR
+$578K

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$321K
2
EMR icon
Emerson Electric
EMR
+$270K
3
IT icon
Gartner
IT
+$250K
4
ADSK icon
Autodesk
ADSK
+$55.9K
5
TECH icon
Bio-Techne
TECH
+$54K

Sector Composition

Rank Sector Weight
1 Healthcare 26.45%
2 Technology 26.19%
3 Industrials 22.35%
4 Materials 13%
5 Communication Services 3.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MLM icon
1
Martin Marietta Materials
MLM
$31.5B
$8.68M 4.27%
43,125
+2,800
+7% +$523K
BDX icon
2
Becton Dickinson
BDX
$45.6B
$7.9M 3.89%
32,429
+2,307
+8% +$545K
ADSK icon
3
Autodesk
ADSK
$49.5B
$7.73M 3.8%
49,600
-374
-0.7% -$55.9K
ROP icon
4
Roper Technologies
ROP
$38.8B
$7.7M 3.79%
22,505
+42
+0.2% +$12.8K
EW icon
5
Edwards Lifesciences
EW
$49.6B
$7.45M 3.67%
116,850
HEI icon
6
HEICO Corp
HEI
$49.8B
$6.9M 3.39%
72,731
INFO
7
DELISTED
IHS Markit Ltd. Common Shares
INFO
$6.83M 3.36%
125,609
-100
-0.1% -$5.23K
TECH icon
8
Bio-Techne
TECH
$11.2B
$6.82M 3.35%
137,400
-1,200
-0.9% -$54K
DHR icon
9
Danaher
DHR
$137B
$6.47M 3.18%
55,311
+5,640
+11% +$578K
MIDD icon
10
Middleby
MIDD
$6.04B
$6.43M 3.16%
49,465
+5,800
+13% +$696K
MKC icon
11
McCormick & Company Non-Voting
MKC
$13.7B
$6.26M 3.08%
83,100
+4,300
+5% +$290K
TMO icon
12
Thermo Fisher Scientific
TMO
$213B
$6.25M 3.07%
22,820
ANSS
13
DELISTED
Ansys
ANSS
$5.69M 2.8%
31,150
-1,900
-6% -$321K
EPAM icon
14
EPAM Systems
EPAM
$5.51B
$5.67M 2.79%
33,500
LII icon
15
Lennox International
LII
$14.4B
$5.49M 2.7%
20,750
FISV
16
Fiserv Inc
FISV
$28.8B
$5.38M 2.65%
61,000
+700
+1% +$57.8K
TFX icon
17
Teleflex
TFX
$6.05B
$5.37M 2.64%
17,775
-45
-0.3% -$12.5K
IFF icon
18
International Flavors & Fragrances
IFF
$20.2B
$5.22M 2.57%
40,500
+1,500
+4% +$199K
EMR icon
19
Emerson Electric
EMR
$83.9B
$5.18M 2.55%
75,586
-4,099
-5% -$270K
IT icon
20
Gartner
IT
$10.1B
$5.11M 2.51%
33,700
-1,800
-5% -$250K
RVTY icon
21
Revvity
RVTY
$12.6B
$4.88M 2.4%
50,600
+1,400
+3% +$126K
PTC icon
22
PTC
PTC
$15.8B
$4.77M 2.35%
51,780
+100
+0.2% +$8.85K
WWD icon
23
Woodward
WWD
$21.3B
$4.66M 2.29%
49,150
-200
-0.4% -$17.7K
XYL icon
24
Xylem
XYL
$27.3B
$4.59M 2.26%
58,070
+400
+0.7% +$29.2K
PAYX icon
25
Paychex
PAYX
$41.6B
$4.44M 2.18%
55,375
-37
-0.1% -$2.73K

Similar funds

Stone Run Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Stone Run Capital held 61 positions worth $203M, up 27% from $161M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Stone Run Capital deployed $11.4M of net new capital in Q1 2019, opening 2 new positions and adding to 15 existing holdings. Its largest new stake was Linde: 20,250 shares worth $3.56M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Ansys, an estimated $321K trimmed.

  • Stone Run Capital's largest Q1 2019 buy was Linde: 20,250 shares worth $3.56M.
  • Stone Run Capital added most to Wabtec in Q1 2019, an estimated $2.79M increase.
  • Stone Run Capital's biggest Q1 2019 reduction was Ansys, cutting an estimated $321K.
  • Stone Run Capital's ten largest holdings make up 36% of its $203M portfolio in Q1 2019.
  • Stone Run Capital opened 2 new positions and closed 0 in Q1 2019.
  • Stone Run Capital's portfolio value rose 27% quarter-over-quarter to $203M.

Based on Stone Run Capital's 13F filing for Q1 2019, filed 14 May 2019.